Cytokine treatment optimises the immunotherapeutic effects of umbilical cord-derived MSC for treatment of inflammatory liver disease

BACKGROUND: Mesenchymal stromal cells (MSC) possess immunomodulatory properties and low immunogenicity, both crucial properties for their development into an effective cellular immunotherapy. They have shown benefit in clinical trials targeting liver diseases; however the efficacy of MSC therapy wil...

Descripción completa

Detalles Bibliográficos
Autores principales: de Witte, Samantha F. H., Merino, Ana M., Franquesa, Marcella, Strini, Tanja, van Zoggel, Johanna A. A., Korevaar, Sander S., Luk, Franka, Gargesha, Madhu, O’Flynn, Lisa, Roy, Debashish, Elliman, Steve J., Newsome, Philip N., Baan, Carla C., Hoogduijn, Martin J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5465593/
https://www.ncbi.nlm.nih.gov/pubmed/28595619
http://dx.doi.org/10.1186/s13287-017-0590-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5465593/
https://www.ncbi.nlm.nih.gov/pubmed/28595619
http://dx.doi.org/10.1186/s13287-017-0590-6

Ejemplares similares